BioMarin drug for genetic disorder succeeds in late-stage study

(Reuters) - BioMarin Pharmaceutical Inc said preliminary data showed its experimental drug met the main goal of reducing blood phenylalanine in patients with a genetic disorder, in a late-stage study.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro